Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 316, Issue 1, Pages L119-L130
Publisher
American Physiological Society
Online
2018-10-11
DOI
10.1152/ajplung.00381.2018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A disease looking for innovative drugs: The case of pulmonary arterial hypertension
- (2018) Roberta Joppi et al. European Journal of Internal Medicine
- Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH
- (2018) Jahidur Rashid et al. JOURNAL OF CONTROLLED RELEASE
- Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery
- (2018) Jahidur Rashid et al. MOLECULAR PHARMACEUTICS
- Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)
- (2017) Jahidur Rashid et al. JOURNAL OF CONTROLLED RELEASE
- Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency
- (2017) Nilesh Gupta et al. MOLECULAR PHARMACEUTICS
- Combination Therapy for Pulmonary Arterial Hypertension: A Systematic Review and Meta-analysis
- (2016) Benjamin D. Fox et al. CANADIAN JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension
- (2016) Huan-long Liu et al. CHEST
- Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH
- (2016) Kamrun Nahar et al. PHARMACEUTICAL RESEARCH
- Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
- (2016) Annie Christine Lajoie et al. Lancet Respiratory Medicine
- Novel investigational therapies for treating pulmonary arterial hypertension
- (2015) Mayank Sardana et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21
- (2015) David E. Green et al. PLoS One
- A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension
- (2014) Michie Toba et al. AMERICAN JOURNAL OF PATHOLOGY
- Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats
- (2014) Nilesh Gupta et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension
- (2014) Kamrun Nahar et al. MOLECULAR PHARMACEUTICS
- Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension
- (2013) Abdallah Alzoubi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of collagen deposition on passive and active mechanical properties of large pulmonary arteries in hypoxic pulmonary hypertension
- (2013) Zhijie Wang et al. Biomechanics and Modeling in Mechanobiology
- Pulmonary Vascular Hemodynamic Response to Exercise in Cardiopulmonary Diseases
- (2013) Gregory D. Lewis et al. CIRCULATION
- Describing right ventricular function
- (2013) Anton Vonk-Noordegraaf et al. EUROPEAN RESPIRATORY JOURNAL
- Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
- (2013) Vivek Gupta et al. JOURNAL OF CONTROLLED RELEASE
- Updated Treatment Algorithm of Pulmonary Arterial Hypertension
- (2013) Nazzareno Galiè et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Definitions and Diagnosis of Pulmonary Hypertension
- (2013) Marius M. Hoeper et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency
- (2013) Vivek Gupta et al. MOLECULAR PHARMACEUTICS
- Superoxide Dismutase Mimetic, MnTE-2-PyP, Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension, Pulmonary Vascular Remodeling, and Activation of the NALP3 Inflammasome
- (2012) Leah R. Villegas et al. ANTIOXIDANTS & REDOX SIGNALING
- PEG–PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin
- (2012) Brijeshkumar Patel et al. JOURNAL OF CONTROLLED RELEASE
- Influence of PEI as a core modifying agent on PLGA microspheres of PGE1, a pulmonary selective vasodilator
- (2011) Vivek Gupta et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PLGA Microparticles Encapsulating Prostaglandin E1-Hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)
- (2011) Vivek Gupta et al. PHARMACEUTICAL RESEARCH
- The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension
- (2010) Chen Yen Ooi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- PPARγ regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-κB
- (2010) Xianghuai Lu et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lung Extracellular Superoxide Dismutase Overexpression Lessens Bleomycin-Induced Pulmonary Hypertension and Vascular Remodeling
- (2010) Zachary Van Rheen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension
- (2010) Kohtaro Abe et al. CIRCULATION
- Prognosis of Pulmonary Arterial Hypertension
- (2010) Vallerie V. McLaughlin et al. CIRCULATION
- Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats
- (2010) Eun Kyung KIM et al. RESPIROLOGY
- PPARγ as a potential therapeutic target in pulmonary hypertension
- (2010) Roy L. Sutliff et al. Therapeutic Advances in Respiratory Disease
- Clinical use of sildenafil in pulmonary artery hypertension
- (2010) TP Singh Expert Review of Respiratory Medicine
- Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure
- (2009) Kurt R. Stenmark et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Rosiglitazone Attenuates Chronic Hypoxia–Induced Pulmonary Hypertension in a Mouse Model
- (2009) Rachel E. Nisbet et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- PPAR Activation: A Potential Treatment For Pulmonary Hypertension
- (2009) G. Hansmann et al. Science Translational Medicine
- Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia
- (2008) Kristine D. Estrada et al. Biomechanics and Modeling in Mechanobiology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now